Why the study?
ADMA and SDMA are endothelial dysfunction markers, and the authors aimed to analyze both markers in patients with CAD referred for stress/rest MPS.
Are elevated ADMA and SDMA concentrations associated with transient myocardial ischemia and predictive of cardiovascular mortality in patients with CAD?
Are elevated ADMA and SDMA concentrations associated with transient myocardial ischemia and predictive of cardiovascular mortality in patients with CAD?
Answers are grounded in this paper and cite their sources.
Elevated serum SDMA concentrations may help identify high-risk CAD patients undergoing MPS and independently predict long-term cardiovascular mortality.
OBJECTIVE: Asymmetric and symmetric dimethylarginines (ADMA and SDMA) are endothelial dysfunction markers. ADMA inhibits synthesis of nitric oxide. We aimed to analyze both markers in patients with coronary artery disease (CAD) who were referred for stress/rest myocardial perfusion scintigraphy (MPS). METHODS: All patients underwent a 2-day dipyridamole (DP) stress/rest protocol. Thereafter, patients with transient myocardial perfusion abnormality were followed up and their coronary blood flow was quantitatively assessed. Venous blood was taken before and after DP stress to measure markers. RESULTS: Baseline ADMA and SDMA concentrations were significantly higher in patients with CAD compared with healthy subjects. Pre- and post-stress SDMA concentrations were significantly higher in patients with transient myocardial perfusion abnormality compared with those with negative MPS results. However, ADMA and L-arginine concentrations were not significantly different between the two groups. None of the markers were significantly different between patients with angiographically proven low coronary flow and those with normal coronary flow. Pre-stress SDMA concentrations were an independent predictor of cardiovascular mortality during a 8-year follow-up. CONCLUSIONS: Elevated serum SDMA concentrations may be helpful for selecting high-risk patients with CAD if there is any doubt in interpreting MPS. SDMA concentrations may also predict cardiovascular outcome.
No takes yet. Share an insight, caveat, or question.
Szabó et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: